NASDAQ
No price data available for this timeframe.
Cytokinetics, Incorporated (CYTK) has a current ratio of 4.53x as of Monday, May 25, 2026. This represents a 37.82% decrease compared to its 12-month average of 7.28x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.